美麗中國(00706.HK)指將繼續聯絡業務夥伴以尋求其他業務合作機遇 續停牌
美麗中國控股(00706.HK)公布,自公司股份暫停買賣起,集團一直維持正常業務營運。就廢料低溫熱解業務分部而言,集團將繼續聯絡業務夥伴以尋求其他業務合作機遇,包括探索於中國建造廢舊輪胎熱裂解設施的機遇,藉此擴大集團之產能。就植樹業務分部而言,集團一直與若干業務夥伴一道物色機遇,拓展集團的樹苗業務以及提升植樹及培育技術。
公司指,去年度中國安徽省實施社交隔離措施,對集團於苗圃的樹苗灌溉及施肥極少,今年上半年中國爆發第二波疫情,需要更多時間評估COVID-19爆發對集團樹苗業務的影響。
公司續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.